The drug "Champix" is specificallydeveloped by the German Pharmacological Company Pfizer medicinal product, which is intended to assist smokers in the fight against nicotine addiction. In pharmacies, this medicine can be purchased in the form of coated tablets.
The drug "Champix", an instruction to whichrecommends it as a means to quit smoking in adults, has in its composition an active element of varenicline. Auxiliary components in the tablet core are the following: microcrystalline cellulose, anhydrous calcium hydrogen phosphate, croscarmellose sodium, colloidal silicon dioxide and magnesium stearate. The skin of the dosage form consists of titanium dioxide, polyethylene glycol and various kinds of dyes.
The drug "Champix", an instruction to whichdescribes in detail its pharmacological properties, exhibits its antinicotinic action due to the main active substance. Numerous scientific studies have shown that the release into the body of dopamine and the sense of pleasure from a cigarette arises from the effects of nicotine on nicotinic receptors located in the central nervous system.
Varenix produces the effect that it turns outis sufficient to alleviate the symptoms of quitting and to reduce the craving for a cigarette. This substance has antagonistic activity that does not allow nicotine to bind to the CNS receptors. As a result, the patient does not have the usual pleasure of smoking cigarettes, the symptoms of craving for tobacco are alleviated. Varenix, getting into the body of a smoker, interacts with the same receptors of the brain as nicotine. In this case, the release of dopamine is produced in smaller volumes. Due to this, when applying the drug, some sense of pleasure is delivered, similar to the effect of nicotine on the body, and the person does not feel much discomfort after giving up the cigarette. In addition, the drug blocks nicotinic receptors for tobacco. This process dulls the pleasure of a smoked cigarette.
The drug "Champix", the instruction to which givesdescription of the method of its reception, is intended for internal use. A dose of one milligram of varenicline is recommended two times during the day after a seven-day titration.
Usually the drug "Champix", the course of treatmentappointed specialist, taken within twelve weeks. Prior to the use of the medication, a certain date is appointed, when the complete rejection of nicotine will come. Usually it is between the eighth and fourteenth days from the beginning of the course of treatment. To achieve the most successful result, the patient should be prepared and psychologically. He needs moral support and motivation. After successfully getting rid of nicotine dependence, a specialist can recommend a similar additional course of medication.
The drug "Champix" (instruction warns aboutside effects that are possible during treatment) can cause transient headaches and nausea or vomiting. Sleep disorders and insomnia are also likely. Patients who are difficult to tolerate discomfort from negative side effects can take a reduced dose of medication. Has a drug "Champix" contraindications. It is not prescribed for patients under the age of eighteen, pregnant and breast-feeding women, and also with increased sensitivity to varenicline or any of the excipients.